Engene Therapeutics Inc (ENGN) Directors and Executive Officers - CSIMarket
CSIMarket
 
Engene Therapeutics Inc   (NASDAQ: ENGN)

Engene Therapeutics Inc

Officers & Directors


Paul Hastings
Director

Gerald Brunk
Director

Lota Zoth
Director

Wouter Joustra
Director

Jasper Bos
Director


We have served as the Company s auditor since;

Dr. Richard Glickman
Director

Ronald H. W. Cooper
Chief Executive Officer and Director (Principal Executive Officer)

Ryan Daws
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) ,

Engene Therapeutics Inc currently has 82 employees.






ENGN Management Effectiveness ENGN Revenue per Employee ENGN Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.